PHÂN TÍCH CHI PHÍ TRỰC TIẾP VÀ GIÁN TIẾP TRÊN BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TUÝP 2 ĐIỀU TRỊ NỘI TRÚ TẠI KHOA NỘI TIẾT BỆNH VIỆN ĐA KHOA TRUNG TÂM AN GIANG NĂM 2024-2025

Abstract

Background: Type 2 diabetes mellitus is a common non-communicable disease with a rising prevalence, imposing a significant economic burden. However, studies on treatment costs, including both direct and indirect expenses, remain limited. Objective: To determine the treatment costs and associated factors among inpatients with type 2 diabetes at the Endocrinology Department, An Giang General Hospital in 2024-2025. Materials and methods: A cross-sectional descriptive study was conducted on 270 inpatients at the Endocrinology Department, An Giang General Hospital from June 2024 to March 2025. Data were collected through patient interviews, medical records, and hospital billing statements. Results: The average direct medical cost was 8,163,863 VND, primarily for hospital bed charges (29.5%), medications (26.4%), and surgeries (18.0%). The average direct non-medical cost was 692,904 VND, mainly for transportation (66.9%). The average indirect cost was 3,640,556 VND, with caregivers' lost income accounting for 78.4%. Complications and length of hospital stay were significantly associated with total treatment costs. Conclusion: The study indicates that the main components of type 2 diabetes treatment costs are hospital bed charges, medications, and surgeries. Non-medical costs are primarily related to transportation, while indirect costs mainly stem from caregivers' lost income. Complications and length of hospital stay are key factors associated with the total cost of treatment.